Mary Ann Liebert, Inc., publishers

A naturally occurring line of immunodeficient pigs can support the growth of human tumors injected under their skin, offering a promising new large animal model for studying human cancers and testing new drugs and treatment strategies.

To enable greater reliance on renewable biomass resources for power generation, combination approaches such as co-firing of high percentages of biomass with coal offer unique advantages, but also significant challenges.

A small, naturally occurring nucleic acid sequence, called a microRNA, known to regulate a number of different cancers, appears to alter the activity of the androgen receptor, which plays a critical role in prostate cancer.

Remote presence robots are used in intensive care units (ICUs) to help critical care physicians supplement on-site patient visits and maintain more frequent patient interactions.

Genetic tests exist to identify risk for the rare inherited form of early-onset Alzheimer’s disease (AD) and to predict susceptibility to the more common, late-onset form of AD, but do people want to know, and how do they react?

More than half (52%) of the companies comprising the tissue engineering (TE) and stem cell industries are revenue-generating, compared to about 21% four years ago, reports Genetic Engineering & Biotechnology News (GEN).

Games that promote health can improve the well-being of employees, saving employers direct and indirect health care costs.

Gene therapy to replace the protein missing in Pompe disease can be effective if the patient’s immune system does not react against the therapy.

A single-dose vaccine capable of providing immunity against the effects of cocaine offers a novel and groundbreaking strategy for treating cocaine addiction is described in an article published Instant Online in Human Gene Therapy.

“The U.S. remains the world’s major superpower but its dominance in biopharma is slipping,” reports Genetic Engineering & Biotechnology News (GEN).